PMV Pharmaceuticals(PMVP) - 2023 Q4 - Annual Results

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights PRINCETON, N.J., February 29, 2024 - PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update. "PMV continues to make significant progress with rezatapopt, a first-in-class precision on ...